Cargando…

Coronavirus Disease 2019 Mitigation Strategies Were Associated With Decreases in Other Respiratory Virus Infections

Detection of diverse respiratory viruses in Boston was approximately 80% lower after practices were instituted to limit coronavirus disease 2019 (COVID-19) spread compared with the same time period during the previous 5 years. Continuing the strategies that lower COVID-19 dissemination may be useful...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinha, Pranay, Reifler, Katherine, Rossi, Michael, Sagar, Manish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083776/ https://www.ncbi.nlm.nih.gov/pubmed/34514014 http://dx.doi.org/10.1093/ofid/ofab105

Ejemplares similares

Combination Therapy With Tocilizumab and Dexamethasone Cost-Effectively Reduces Coronavirus Disease 2019 Mortality
por: Sinha, Pranay, et al.
Publicado: (2021)

Fecal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) RNA Is Associated With Decreased Coronavirus Disease 2019 (COVID-19) Survival
por: Das Adhikari, Upasana, et al.
Publicado: (2021)

Decreased Risk of Coronavirus Disease 2019–Related Hospitalization Associated With the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2
por: Ridgway, Jessica P, et al.
Publicado: (2022)

An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019
por: Bordoni, Veronica, et al.
Publicado: (2020)

Coinfection with severe acute respiratory syndrome coronavirus‐2 and other respiratory viruses at a tertiary hospital in Korea
por: Kim, Zehwan, et al.
Publicado: (2021)

The Removal of Airborne Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Other Microbial Bioaerosols by Air Filtration on Coronavirus Disease 2019 (COVID-19) Surge Units
por: Conway Morris, Andrew, et al.
Publicado: (2021)

The Time Sequences of Respiratory and Rectal Viral Shedding in Patients With Coronavirus Disease 2019
por: Zhao, Fang, et al.
Publicado: (2020)

Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019
por: Regan, James, et al.
Publicado: (2021)

Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019
por: Sakoulas, George, et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus-2 IgG antibody response to coronavirus disease 2019 vaccination in South Indian health-care professionals with and without coronavirus disease 2019 exposure
por: Jayashri, Ramamoorthy, et al.
Publicado: (2022)

Awake Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 Acute Respiratory Failure
por: Assanangkornchai, Nawaporn, et al.
Publicado: (2021)

The Epidemiology of Respiratory Syncytial Virus in New York City during the Coronavirus Disease-2019 Pandemic Compared with Previous Years
por: Halabi, Katia C., et al.
Publicado: (2022)

Clinical Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Tests for Diagnosing Coronavirus Disease 2019
por: Ridgway, Jessica P, et al.
Publicado: (2020)

Tropism of Severe Acute Respiratory Syndrome Coronavirus 2 for Barrett’s Esophagus May Increase Susceptibility to Developing Coronavirus Disease 2019
por: Jin, Ramon U., et al.
Publicado: (2021)

Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2–Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients
por: Haidar, Ghady, et al.
Publicado: (2023)

Prolonged shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) RNA among patients with coronavirus disease 2019 (COVID-19)
por: Ridgway, Jessica P., et al.
Publicado: (2020)

Characterization of handheld disinfectant sprayers for effective surface decontamination to mitigate severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission
por: Kim, Seong Chan, et al.
Publicado: (2021)

Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure
por: Alladina, Jehan W., et al.
Publicado: (2021)

Immature Platelet Fraction as a Biomarker for Disease Severity in Pediatric Respiratory Coronavirus Disease 2019
por: Lee, Nicholas C.J., et al.
Publicado: (2022)

Assessment of Coronavirus Disease 2019 Intervention Strategies in the Nordic Countries Using Genomic Epidemiology
por: Duchene, Sebastian, et al.
Publicado: (2022)

Evaluation of Albumin Kinetics in Critically Ill Patients With Coronavirus Disease 2019 Compared to Those With Sepsis-Induced Acute Respiratory Distress Syndrome
por: Su, Chang, et al.
Publicado: (2021)

Understanding the Potential Drivers for Respiratory Syncytial Virus Rebound During the Coronavirus Disease 2019 Pandemic
por: Li, You, et al.
Publicado: (2022)

Dorsal Push and Abdominal Binding Improve Respiratory Compliance and Driving Pressure in Proned Coronavirus Disease 2019 Acute Respiratory Distress Syndrome
por: Elmufdi, Firas S., et al.
Publicado: (2021)

Thromboelastography to Detect Hypercoagulability and Reduced Fibrinolysis in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Patients
por: Sadd, Corey, et al.
Publicado: (2020)

Clinical Distancing and Mitigation of Coronavirus Disease 2019
por: Scott, Benjamin K., et al.
Publicado: (2020)

Risk of Symptomatic Infection During a Second Coronavirus Disease 2019 Wave in Severe Acute Respiratory Syndrome Coronavirus 2–Seropositive Individuals
por: Manica, Mattia, et al.
Publicado: (2021)

Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine( )
por: Maron, Jenny S, et al.
Publicado: (2022)

Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down Syndrome
por: Streng, Bianca M M, et al.
Publicado: (2022)

Estimating data-driven coronavirus disease 2019 mitigation strategies for safe university reopening
por: Yang, Qihui, et al.
Publicado: (2022)

Holistic strategies to mitigate the economic, societal, and health burden of the Coronavirus disease-2019 pandemic
por: Basu, Amitava, et al.
Publicado: (2022)

Yield of Severe Acute Respiratory Syndrome Coronavirus 2 Lower Respiratory Tract Testing After a Negative Nasopharyngeal Test Among Hospitalized Persons Under Investigation for Coronavirus Disease 2019
por: Egbuonu, Kenechukwu, et al.
Publicado: (2021)

Community Coronavirus Disease 2019 Activity Level and Nursing Home Staff Testing for Active Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Indiana
por: Blackburn, Justin, et al.
Publicado: (2021)

Longitudinal Neutralizing and Functional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants Following Messenger RNA Coronavirus Disease 2019 Vaccination
por: Chen, Xuemin, et al.
Publicado: (2023)

Coronavirus Disease 2019 Pandemic–related Colorectal Cancer Screening Delays Impact Unscreened Older Adults the Most, But Mitigation Strategies Exist
por: Sharaf, Ravi N., et al.
Publicado: (2022)

Decreased Use of Broad-Spectrum Antibiotics During the Coronavirus Disease 2019 Epidemic in South Korea
por: Ryu, Sukhyun, et al.
Publicado: (2021)

Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010–2011 to 2016–2017
por: Skowronski, Danuta M, et al.
Publicado: (2020)

Incidence and outcomes of hospital-associated coronavirus disease 2019 (COVID-19) before and after emergence of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant
por: Williams, Victoria R., et al.
Publicado: (2023)

Lower Severe Acute Respiratory Syndrome Coronavirus 2 Viral Shedding Following Coronavirus Disease 2019 Vaccination Among Healthcare Workers in Los Angeles, California
por: Adamson, Paul C, et al.
Publicado: (2021)

The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19)
por: Mirzaei, Rasoul, et al.
Publicado: (2021)

Presence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 on Admission Is Associated With Decreased Mortality in COVID-19 Critical Illness
por: Mabrey, F. Linzee, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_89b63jikngkeej5m6s3hufrusn